Lönnroth P, Digirolamo M, Krotkiewski M, Smith U
Diabetes. 1983 Aug;32(8):748-54. doi: 10.2337/diab.32.8.748.
Adipose tissue was obtained from 66 individuals including 21 patients with type II diabetes of different severity (16 SU-treated and 5 diet-treated only) as well as 9 obese subjects with reduced glucose tolerance. Adipocyte insulin binding, antilipolytic effect of insulin, and glucose incorporation into triglycerides were measured in the diabetic and the obese subjects and the data compared with that of normal controls of similar age and relative weight. Insulin binding per cell was normal in the diabetic patients and was significantly increased at low insulin concentrations in the obese patients with reduced glucose tolerance, suggesting increased affinity. Furthermore, insulin binding correlated negatively with age but, when age was corrected for, did not correlate significantly with fasting insulin or glucose levels, relative body weight, or fat cell size. Insulin sensitivity, measured as the antilipolytic effect of insulin, was similar in all patient groups. Patients with the most severe type II diabetes (SU-treated group) demonstrated, in contrast to the less severely diabetic patients, a marked reduction in both basal and insulin-stimulated glucose incorporation into triglycerides showing the presence of a pronounced postreceptor defect. The insulin effect on glucose incorporation correlated negatively with the fasting glucose levels, suggesting that the postreceptor defect seen in the adipocyte reflects perturbations in other organs, like muscle or liver, of greater importance for glucose homeostasis.
从66名个体获取脂肪组织,其中包括21名不同严重程度的II型糖尿病患者(16名接受磺脲类药物治疗,5名仅接受饮食治疗)以及9名糖耐量降低的肥胖受试者。在糖尿病患者和肥胖受试者中测量脂肪细胞胰岛素结合、胰岛素的抗脂解作用以及葡萄糖掺入甘油三酯的情况,并将数据与年龄和相对体重相似的正常对照者的数据进行比较。糖尿病患者每个细胞的胰岛素结合正常,而糖耐量降低的肥胖患者在低胰岛素浓度下胰岛素结合显著增加,提示亲和力增加。此外,胰岛素结合与年龄呈负相关,但校正年龄后,与空腹胰岛素或血糖水平、相对体重或脂肪细胞大小无显著相关性。以胰岛素的抗脂解作用衡量的胰岛素敏感性在所有患者组中相似。与病情较轻的糖尿病患者相比,最严重的II型糖尿病患者(磺脲类药物治疗组)基础和胰岛素刺激的葡萄糖掺入甘油三酯均显著降低,表明存在明显的受体后缺陷。胰岛素对葡萄糖掺入的作用与空腹血糖水平呈负相关,提示脂肪细胞中所见的受体后缺陷反映了对葡萄糖稳态更为重要的其他器官(如肌肉或肝脏)的紊乱。